Abstract
Uncontrolled growth and diffused invasion are major causes of mortality in patients with malignant gliomas. Nodal has been shown to have a central role in the tumorigenic signaling pathways of malignant melanoma. In this study, we show that grade IV human glioma cell lines expressed different levels of Nodal, paralleled to the potential for cell invasiveness. Treatment of glioma cell lines with recombinant Nodal (rNodal) increased matrix metalloproteinase 2 (MMP-2) secretion and cell invasiveness. The ectopic expression of Nodal in GBM glioma cells that expressed Nodal at low level resulted in increased MMP-2 secretion, enhanced cell invasiveness, raised cell proliferation rates in vitro, increased tumor growth in vivo, and was associated with poor survival in a mice xenograft model. In contrast, the knockdown of Nodal expression in U87MG glioma cells with high Nodal expression level had reduced MMP-2 secretion, less cell invasiveness, lower tumor growth in vivo and longer lifespan in mice with U87MG/shNodal cell xenografts. In addition, Nodal knockdown promoted the reversion of malignant glioma cells toward a differentiated astrocytic phenotype. Furthermore, our data support the notion that Nodal may regulate glioma progression through the induction of the leukemia inhibitory factor (LIF) and Cripto-1 through activated Smad.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bennett JT, Stickney HL, Choi WY, Ciruna B, Talbot WS, Schier AF . (2007). Maternal nodal and zebrafish embryogenesis. Nature 450: E1–E2; discussion E2-4.
Besser D . (2004). Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 279: 45076–45084.
Brennan J, Norris DP, Robertson EJ . (2002). Nodal activity in the node governs left-right asymmetry. Genes Dev 16: 2339–2344.
Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, Arias A et al. (2007). High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147–160.
Candolfi M, Curtin JF, Nichols WS, Muhammad AG, King GD, Pluhar GE et al. (2007). Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 85: 133–148.
Chakravarti A, Palanichamy K . (2008). Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. Cancer Treat Res 139: 173–189.
Christiansen JJ, Rajasekaran AK . (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319–8326.
Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM . (2007). Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246–255.
Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ et al. (2004). SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3: 737–745.
Jan HJ, Lee CC, Shih YL, Hueng DY, Ma HI, Lai JH et al. (2010). Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro-Oncology 12: 58–70.
Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M et al. (2008). Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 27: 4830–4840.
Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK et al. (2001). Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20: 6669–6678.
Ma HI, Guo P, Li J, Lin SZ, Chiang YH, Xiao X et al. (2002a). Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res 62: 756–763.
Ma HI, Lin SZ, Chiang YH, Li J, Chen SL, Tsao YP et al. (2002b). Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Therapy 9: 2–11.
Mancino M, Strizzi L, Wechselberger C, Watanabe K, Gonzales M, Hamada S et al. (2008). Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells. J Cell Physiol 215: 192–203.
Nonaka S, Shiratori H, Saijoh Y, Hamada H . (2002). Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 418: 96–99.
Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I et al. (2009). TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15: 315–327.
Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157–173.
Postovit LM, Margaryan NV, Seftor EA, Hendrix MJ . (2008a). Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res 21: 348–357.
Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW et al. (2008b). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329–4334.
Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ . (2000). The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82: 52–55.
Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K et al. (1997). Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87: 420–430.
Saha S, Ji L, de Pablo JJ, Palecek SP . (2008). TGFbeta/activin/Nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain. Biophys J 94: 4123–4133.
Smith JR, Vallier L, Lupo G, Alexander M, Harris WA, Pedersen RA . (2008). Inhibition of activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol 313: 107–117.
Strizzi L, Hardy KM, Seftor EA, Costa FF, Kirschmann DA, Seftor RE et al. (2009). Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res 69: 7131–7134.
Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE et al. (2008). Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29: 91–103.
Strojnik T, Kavalar R, Lah TT . (2006). Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res 26: 2887–2900.
Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287–300.
Svechnikova I, Almqvist PM, Ekstrom TJ . (2008). HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. Int J Oncol 32: 821–827.
Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925–932.
Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R et al. (2004). SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 64: 7954–7961.
Vallier L, Alexander M, Pedersen RA . (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118: 4495–4509.
Vallier L, Reynolds D, Pedersen RA . (2004). Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275: 403–421.
Wick W, Naumann U, Weller M . (2006). Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12: 341–349.
Zhou R, Skalli O . (2000). TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 254: 269–278.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
This article is cited by
-
Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance
Cell Death & Disease (2023)
-
Downregulation of Nodal inhibits metastatic progression in retinoblastoma
Acta Neuropathologica Communications (2019)
-
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
Oncogene (2019)
-
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
Scientific Reports (2017)
-
Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development
Journal of Molecular Medicine (2017)